side effects of ro glp 1 Important Safety Information for GLP-1s The Complete Guide to Weight

n=118) *Values are Mean SD Type 1 Diabetes Pediatric (see Table 7) A randomized, 16-week, open-label, parallel design study of pediatric patients with type 1 diabetes (n=298) aged 4-18 years compared two subcutaneous infusion regimens administered via an external insulin pump: NOVOLOG (n=198) or insulin lispro (n=100)

We break it all down in our visual guide below

Semaglutide: Primarily approved for type 2 diabetes and weight management, it works by increasing insulin secretion and reducing appetite

Available online at: (accessed April, 2026)

Not everyone is a candidate for either drug see our full guide on who should avoid GLP-1 medications before starting

This is consistent with previous anatomical and functional studies of the OB and hypothalamus